BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37772080)

  • 21. Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
    Giordano TJ
    Curr Opin Oncol; 2016 Jan; 28(1):1-4. PubMed ID: 26569424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
    Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annotation-Free Deep Learning-Based Prediction of Thyroid Molecular Cancer Biomarker BRAF (V600E) from Cytological Slides.
    Wang CW; Muzakky H; Lee YC; Lin YJ; Chao TK
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.
    Park JY; Yi JW; Park CH; Lim Y; Lee KH; Lee KE; Kim JH
    Cancer Genomics Proteomics; 2016; 13(2):171-81. PubMed ID: 26912807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of the extent of BRAF
    Liu L; Chang JW; Jung SN; Park HS; Oh T; Lim YC; Koo BS
    Oral Oncol; 2016 Nov; 62():72-77. PubMed ID: 27865374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological Characteristics of Papillary Thyroid Cancer in Children with Emphasis on Pubertal Status and Association with BRAF
    Poyrazoğlu Ş; Bundak R; Baş F; Yeğen G; Şanlı Y; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):185-193. PubMed ID: 28077340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.
    Barbaro D; Incensati RM; Materazzi G; Boni G; Grosso M; Panicucci E; Lapi P; Pasquini C; Miccoli P
    Endocrine; 2014 Apr; 45(3):462-8. PubMed ID: 23925579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.
    Tallini G; de Biase D; Durante C; Acquaviva G; Bisceglia M; Bruno R; Bacchi Reggiani ML; Casadei GP; Costante G; Cremonini N; Lamartina L; Meringolo D; Nardi F; Pession A; Rhoden KJ; Ronga G; Torlontano M; Verrienti A; Visani M; Filetti S
    Mod Pathol; 2015 Oct; 28(10):1343-59. PubMed ID: 26271724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.
    Niederer-Wüst SM; Jochum W; Förbs D; Brändle M; Bilz S; Clerici T; Oettli R; Müller J; Haile SR; Ess S; Stoeckli SJ; Broglie MA
    Surgery; 2015 Jan; 157(1):119-25. PubMed ID: 25482468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma.
    He W; Sun Y; Ge J; Wang X; Lin B; Yu S; Li Y; Hong S; Xiao H
    Front Endocrinol (Lausanne); 2023; 14():1076640. PubMed ID: 36843593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.
    Staubitz JI; Müller C; Heymans A; Merten C; Roos B; Poplawski A; Ludt A; Strobl S; Springer E; Schad A; Roth W; Musholt TJ; Hartmann N
    BJS Open; 2023 May; 7(3):. PubMed ID: 37146205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cho U; Mete O; Kim MH; Bae JS; Jung CK
    Mod Pathol; 2017 Jun; 30(6):810-825. PubMed ID: 28281551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.
    Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD
    Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.
    Kim SJ; Lee KE; Myong JP; Park JH; Jeon YK; Min HS; Park SY; Jung KC; Koo do H; Youn YK
    World J Surg; 2012 Feb; 36(2):310-7. PubMed ID: 22190222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.
    Ricarte-Filho J; Ganly I; Rivera M; Katabi N; Fu W; Shaha A; Tuttle RM; Fagin JA; Ghossein R
    Thyroid; 2012 Jun; 22(6):575-84. PubMed ID: 22471242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
    Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
    Huang M; Yan C; Xiao J; Wang T; Ling R
    Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Animal Model Further Uncovers the Role of Mutant Braf
    Koelsch B; Theurer S; Staniszewska M; Heupel J; Koch A; Mergener S; Walk F; Fischer C; Kutritz A; Schmid KW; Kindler-Röhrborn A
    Am J Pathol; 2020 Mar; 190(3):702-710. PubMed ID: 31953036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia.
    Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Pupic G; Zivkovic O; Markovic I; Djurisic I; Buta M; Dimitrijevic B; Rogounovitch T; Mitsutake N; Mine M; Shibata Y; Nakashima M; Yamashita S
    Endocr J; 2011; 58(5):381-93. PubMed ID: 21498916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.